Artículos del autor

solaci

Antithrombotic Anticoagulants

Galileo: Rivaroxaban After TAVR Stopped Due to Early Event Rates

Patients undergoing transcatheter aortic valve replacement (TAVR) randomized to rivaroxaban in the GALILEO trial experienced higher risk...
solaci -
Events

34th Uruguayan Cardiology Congress

The 34th Cardiology Congress of the Uruguayan Cardiology Society (SUC) will be held on December 2 thru...
solaci -
Other

MR CLEAN Registry: “Time is Brain” is a Far More Accurate than “Time is Heart”

Time to endovascular treatment after ischemic stroke is strongly associated to functional outcomes. This association could be even...
solaci -
Structural heart disease

Immediate Electrocardiography After TAVI, the Simplest Way to Predict Conduction Disorders

Taking into account a simple 12-lead electrocardiography performed immediately after transcatheter aortic valve implantation (TAVI), removing the...
solaci -
Femoral

Exercise Programs in Peripheral Artery Disease

Programmed exercises are recommended as initial management strategy for patients with peripheral artery disease (PAD). Most exercise programs...
solaci -
Institutional News

Discover the Scientific Program of Peru Sessions 2018

SOLACI Regional Sessions, to be held in Lima, Peru, on October 25 and 26, at the Main...
solaci -
Acute coronary syndromes

Safety of Lesion Deferral with iFR or FFR in Both Stable and Acute Patients

Overall, deferral of lesion revascularization is equally safe with both fractional flow reserve (FFR) and instantaneous wave-free...
solaci -
Structural heart disease

Ambulatory Continuous Monitoring in Patients with Left Bundle Branch Block After TAVI

The incidence of arrhythmic events up to a year after implantation is high and involves almost half...
solaci -